ABDERA THERAPEUTICS Trademark

Trademark Overview


On Wednesday, January 26, 2022, a trademark application was filed for ABDERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ABDERA THERAPEUTICS trademark a serial number of 97240018. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Abdera Therapeutics Inc.. The ABDERA THERAPEUTICS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

chemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic imaging agents for use in diagnosing cancer

medical kits comprised of medical syringes and single and multi-dose vials of glass, sold empty, for administering pharmaceutical products used for the treatment, prevention, and diagnosis of cancer

pharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors and cancer
abdera therapeutics

General Information


Serial Number97240018
Word MarkABDERA THERAPEUTICS
Filing DateWednesday, January 26, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Goods and Serviceschemicals for pharmaceutical use, namely, for the treatment, prevention, or diagnosis of cancer; pharmaceutical drugs used for the treatment, prevention, or diagnosis of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products used for the treatment, prevention, and diagnosis of cancer; pharmaceutical products for use in relation to radiotherapy, namely, products to target and treat tumors and cancer; pharmaceutical preparations, namely, pharmaceuticals using alpha radiation therapies for the treatment of cancer; diagnostic imaging agents for use in diagnosing cancer
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesmedical kits comprised of medical syringes and single and multi-dose vials of glass, sold empty, for administering pharmaceutical products used for the treatment, prevention, and diagnosis of cancer
Goods and Servicespharmaceutical drug development services, namely, drug development for the treatment of cancer; research and development of pharmaceutical products using radiotherapy to target and treat tumors and cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbdera Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, BC V6T1Z3
CA

Party NameAbdera Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6T1Z3
CA

Trademark Events


Event DateEvent Description
Saturday, January 29, 2022NEW APPLICATION ENTERED
Tuesday, November 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 4, 2022ASSIGNED TO EXAMINER
Tuesday, November 15, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 15, 2022NON-FINAL ACTION E-MAILED
Monday, May 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 14, 2024SOU EXTENSION 1 FILED
Wednesday, February 14, 2024SOU EXTENSION 1 GRANTED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, August 14, 2024SOU EXTENSION 2 FILED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 14, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED